Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.
Lopez-Soley E, Martinez-Heras E, Andorra M, Solanes A, Radua J, Montejo C, Alba-Arbalat S, Sola-Valls N, Pulido-Valdeolivas I, Sepulveda M, Romero-Pinel L, Munteis E, Martínez-Rodríguez JE, Blanco Y, Martinez-Lapiscina EH, Villoslada P, Saiz A, Solana E, Llufriu S. Lopez-Soley E, et al. Among authors: sola valls n. J Pers Med. 2021 Oct 28;11(11):1107. doi: 10.3390/jpm11111107. J Pers Med. 2021. PMID: 34834459 Free PMC article.
Impact of Cognitive Reserve and Structural Connectivity on Cognitive Performance in Multiple Sclerosis.
Lopez-Soley E, Solana E, Martínez-Heras E, Andorra M, Radua J, Prats-Uribe A, Montejo C, Sola-Valls N, Sepulveda M, Pulido-Valdeolivas I, Blanco Y, Martinez-Lapiscina EH, Saiz A, Llufriu S. Lopez-Soley E, et al. Among authors: sola valls n. Front Neurol. 2020 Oct 30;11:581700. doi: 10.3389/fneur.2020.581700. eCollection 2020. Front Neurol. 2020. PMID: 33193039 Free PMC article.
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients.
Solana E, Martinez-Heras E, Montal V, Vilaplana E, Lopez-Soley E, Radua J, Sola-Valls N, Montejo C, Blanco Y, Pulido-Valdeolivas I, Sepúlveda M, Andorra M, Berenguer J, Villoslada P, Martinez-Lapiscina EH, Prados F, Saiz A, Fortea J, Llufriu S. Solana E, et al. Among authors: sola valls n. Sci Rep. 2021 Aug 19;11(1):16805. doi: 10.1038/s41598-021-96132-x. Sci Rep. 2021. PMID: 34413373 Free PMC article.
Predictors of vision impairment in Multiple Sclerosis.
Sanchez-Dalmau B, Martinez-Lapiscina EH, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Blanco Y, Sola-Valls N, Sepulveda M, Guerrero A, Alba S, Andorra M, Camos A, Sanchez-Vela L, Alfonso V, Saiz A, Villoslada P. Sanchez-Dalmau B, et al. PLoS One. 2018 Apr 17;13(4):e0195856. doi: 10.1371/journal.pone.0195856. eCollection 2018. PLoS One. 2018. PMID: 29664921 Free PMC article.
Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
Andorra M, Nakamura K, Lampert EJ, Pulido-Valdeolivas I, Zubizarreta I, Llufriu S, Martinez-Heras E, Sola-Valls N, Sepulveda M, Tercero-Uribe A, Blanco Y, Saiz A, Villoslada P, Martinez-Lapiscina EH. Andorra M, et al. JAMA Neurol. 2018 Oct 1;75(10):1246-1255. doi: 10.1001/jamaneurol.2018.1596. JAMA Neurol. 2018. PMID: 29971335 Free PMC article.
Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.
Solà-Valls N, Vicente-Pascual M, Blanco Y, Solana E, Llufriu S, Martínez-Heras E, Martínez-Lapiscina EH, Sepúlveda M, Pulido-Valdeolivas I, Zubizarreta I, Saiz A. Solà-Valls N, et al. Mult Scler Relat Disord. 2019 Jan;27:333-339. doi: 10.1016/j.msard.2018.11.018. Epub 2018 Nov 19. Mult Scler Relat Disord. 2019. PMID: 30472411
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.
Sepulveda M, Delgado-García G, Blanco Y, Sola-Valls N, Martinez-Lapiscina EH, Armangué T, Montejo C, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Escudero D, Ruiz-García R, Llufriu S, Dalmau J, Graus F, Saiz A. Sepulveda M, et al. Neurol Neuroimmunol Neuroinflamm. 2019 Aug 30;6(6):e607. doi: 10.1212/NXI.0000000000000607. Print 2019 Nov. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31471461 Free PMC article.
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.
Andorrà M, Alba-Arbalat S, Camos-Carreras A, Gabilondo I, Fraga-Pumar E, Torres-Torres R, Pulido-Valdeolivas I, Tercero-Uribe AI, Guerrero-Zamora AM, Ortiz-Perez S, Zubizarreta I, Sola-Valls N, Llufriu S, Sepulveda M, Martinez-Hernandez E, Armangue T, Blanco Y, Villoslada P, Sanchez-Dalmau B, Saiz A, Martinez-Lapiscina EH. Andorrà M, et al. JAMA Neurol. 2020 Feb 1;77(2):234-244. doi: 10.1001/jamaneurol.2019.3283. JAMA Neurol. 2020. PMID: 31566686 Free PMC article.
51 results